Clinical comparative study of sulbactam/ampicillin and imipenem/cilastatin in elderly patients with community-acquired pneumonia

Internal Medicine

Volumn 45, Issue 17, 2006, Pages 995-999

  Yanagihara, Katsunori ^a   Fukuda, Yuichi ^a   Seki, Masafumi ^a   Izumikawa, Koichi ^a   Higashiyama, Yasuhito ^a   Miyazaki, Yoshitsugu ^a   Hirakata, Yoichi ^a   Tomono, Kazunori ^a   Mizuta, Yohei ^a   Tsukamoto, Kazuhiro ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Antibiotics; Clinical trial; Community acquired pneumonia; Elderly patients; Pulmonary infection

Indexed keywords

CILASTATIN PLUS IMIPENEM; METICILLIN; POTASSIUM; SULTAMICILLIN;

AGED; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIOLOGY; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; ENTEROBACTER AEROGENES; EOSINOPHILIA; FEMALE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; HYPERKALEMIA; KLEBSIELLA PNEUMONIAE; LIVER DYSFUNCTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SANGUINIS; THORAX RADIOGRAPHY; TREATMENT DURATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMPICILLIN; ANTI-BACTERIAL AGENTS; CILASTATIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG COMBINATIONS; FEMALE; HUMANS; IMIPENEM; MALE; PNEUMONIA, BACTERIAL; PROSPECTIVE STUDIES; PROTEASE INHIBITORS; SEVERITY OF ILLNESS INDEX; SULBACTAM; TREATMENT OUTCOME;

EID: 33749502480     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1717     Document Type: Article

References (17)

1. Health and Welfare Statistics Association. Kokumin Eisei no Doko. J Health Welfare Stat 50-52, 2003 (in Japanese).
2. Ferrara AM, Fietta AM. New developments in antibacterial choice for lower respiratory tract infections in elderly patients. Drugs Aging 21: 167-186, 2004.
3. Yamaya M, Yanai M, Ohrui T, Arai H, Sasaki H. Interventions to prevent pneumonia among older adults. J Am Geriatr Soc 49: 85-90, 2001.
4. Hirakata Y, Izumikawa K, Yamaguchi T, et al. Rapid detection and evaluation of clinical characteristics of emerging multiple-drug-resistant gram-negative rods carrying the metallo-beta-lactamase gene blaIMP. Antimicrob Agents Chemother 42: 2006-2011, 1998.
5. Ishida T, Hashimoto T, Arita M, Ito I, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 114: 1588-1593, 1998.
6. Matsushima T, Miyashita. N, File TM Jr. Etiology and management of community-acquired pneumonia in Asia. Curr Opin Infect Dis 15: 157-162, 2002.
7. Miyashita N, Fukano H, Niki Y, Matsushima T, Okimoto N. Etiology of community-acquired pneumonia requiring hospitalization in Japan. Chest 119: 1295-1296, 2001.
8. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163: 1730-1754, 2001.
9. Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336: 243-250, 1997.
10. Matsushima T, Japanese Respiratory Society. The Japanese Respiratory Society guidelines for the management of community-acquired pneumonia in adults. Nippon Rinsho 61(Suppl 2): 677-681. 2003 (in Japanese).
11. Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 157: 1453-1459, 1997.
12. Kaneko H, Kido M. Symptom and emergency health according to the syndrome of the elderly. Rinsho to Kenkyu 82: 613-618, 2005 (in Japanese).
13. Okimoto N, Kurihara T, Honda N, et al. Clinical effect of ampicillin with beta-lactamase inhibitor (sulbactam/ampicillin) on community-acquired pneumonia in the elderly. J Infect Chemother 9: 183-186, 2003.
14. Wood GC, Hanes SD, Croce MA, Fabian TC, Boucher BA. Comparison of ampicillin-sulbactam and imipenem-cilastatin for the treatment of acinetobacter ventilator-associated pneumonia. Clin Infect Dis 34: 1425-1430, 2002.
15. Japanese Respiratory Society, community-acquired pneumonia treatment guideline creation committee. The Japanese Respiratory Society guidelines for the management of community-acquired pneumonia in adults. Japan Respiratory Society, Tokyo, 2005.
16. Gniadkowski M. Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms. Clin Microbiol Infect 7: 597-608, 2001.
17. Crespo MP, Woodford N, Sinclair A, et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metatlo-beta-lactamase, in a tertiary care center in Cali, Colombia. J Clin Microbiol 42: 5094-5101, 2004.